Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117399533 | 11739953 | 3 | F | 20141230 | 20160715 | 20151113 | 20160728 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-075956 | BRISTOL MYERS SQUIBB | 78.18 | YR | M | Y | 0.00000 | 20160728 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117399533 | 11739953 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 1 UNIT, UNK | U | 9218 | 1 | DF | TABLET | ||||||
| 117399533 | 11739953 | 2 | C | REPAGLINIDE SANDOZ | REPAGLINIDE | 1 | Oral | 3 MG, UNK | U | 0 | 3 | MG | TABLET | ||||||
| 117399533 | 11739953 | 3 | C | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 117399533 | 11739953 | 4 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117399533 | 11739953 | 1 | Ischaemic heart disease prophylaxis |
| 117399533 | 11739953 | 2 | Diabetes mellitus |
| 117399533 | 11739953 | 3 | Urinary tract infection |
| 117399533 | 11739953 | 4 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117399533 | 11739953 | OT |
| 117399533 | 11739953 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117399533 | 11739953 | Dehydration | |
| 117399533 | 11739953 | Gastrointestinal haemorrhage | |
| 117399533 | 11739953 | Haemorrhagic anaemia | |
| 117399533 | 11739953 | Melaena | |
| 117399533 | 11739953 | Mucosal dryness | |
| 117399533 | 11739953 | Off label use | |
| 117399533 | 11739953 | Pyrexia | |
| 117399533 | 11739953 | Toxicity to various agents | |
| 117399533 | 11739953 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117399533 | 11739953 | 1 | 20131219 | 20150113 | 0 | |
| 117399533 | 11739953 | 2 | 20141204 | 0 | ||
| 117399533 | 11739953 | 3 | 20141230 | 20150105 | 0 | |
| 117399533 | 11739953 | 4 | 20141230 | 20150105 | 0 |